Looking at the latest Shanghai and Shenzhen 300 industry distribution (as of December 24, 2025), you can truly feel the dramatic changes in the market over these years.
The once main players are now marginalized—liquor and wine combined account for only 5.9%, and the pharmaceutical sector is not even listed separately. I manually checked the individual stock weights, and the entire pharmaceutical sector is only about 5%. This was unimaginable in the past.
In contrast, the three main drivers of technology are expanding: integrated circuits account for 5.4%, electronic components for 6.0%, and electrical equipment and parts for 6.7%. The combined enthusiasm for these sectors clearly surpasses that of traditional consumer and medical industries.
To be honest, a 20-30 year industry cycle has reversed in this way. The once blue-chip stalwarts now have to give way to emerging industries, with capital flowing into hardware and advanced manufacturing. This reflects a profound adjustment in the economic structure—from being driven by consumption and healthcare to being driven by technology and manufacturing. The market is so ruthless; when the trend shifts, yesterday’s kings can easily become supporting roles.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
15 Likes
Reward
15
4
Repost
Share
Comment
0/400
CommunitySlacker
· 8h ago
Baijiu drops to 5.9%, even my fund managers are crying haha
---
This is industry rotation, no one can avoid it. Pharmaceuticals are even worse
---
Chips and electronics are on the rise. Sorry, blue-chip stocks, make way
---
After a long struggle, I realize I can't beat hard technology. Feeling exhausted
---
Funds are all about profit, chasing hot spots never ends
---
I can't believe pharmaceuticals are only 5%. The times really have changed
---
The combination of integrated circuits + electronic components is too powerful, directly crushing consumer stocks
---
A 20-30 year cycle reversal, retail investors' investment framework should also be updated
---
From drinking and medicine to buying chips, this is the story of China's economic upgrade
---
Baijiu, once a king, has become a supporting role. The joke is quite harsh
View OriginalReply0
SorryRugPulled
· 8h ago
Baijiu and pharmaceuticals have really become supporting roles; technology hardware is the new star. Capital is ruthless.
View OriginalReply0
BearMarketSurvivor
· 8h ago
Baijiu only 5.9%? Well, this time we really need to check out the chips.
---
Pharmaceuticals 5%, how could we have imagined this ten years ago... The times have changed.
---
Hardware and manufacturing are the future, the consumer era should be left behind.
---
Funds are so realistic; they go where the heat is. Yesterday's champions are today’s also-rans.
---
The CSI 300 is heavily weighted towards technology; not following the trend feels like falling behind.
---
The rise of manufacturing is really evident; Baijiu and pharmaceuticals are completely cooling off.
---
When the trend shifts, the valuation gap widens significantly. This market is truly ruthless.
View OriginalReply0
BlockchainBard
· 8h ago
Liquor and pharmaceuticals have really been pushed into the cold storage, and the turnaround is too fast...
Speaking of technology hardware, it doesn't seem that unreasonable to rise now; you just need to get used to the new game rules.
The 5% figure in pharmaceuticals looks truly hopeless; it used to be the absolute C position.
I'm not surprised that integrated circuits are rising; manufacturing is indeed the trend, and capital always needs an outlet.
The changes in the CSI 300 over the past few years reflect a lot.
Blue-chip stocks falling from grace—that's the cruel reality of the market.
When the wind turns, the difference is huge; you have to learn to switch your mindset quickly.
Looking at the latest Shanghai and Shenzhen 300 industry distribution (as of December 24, 2025), you can truly feel the dramatic changes in the market over these years.
The once main players are now marginalized—liquor and wine combined account for only 5.9%, and the pharmaceutical sector is not even listed separately. I manually checked the individual stock weights, and the entire pharmaceutical sector is only about 5%. This was unimaginable in the past.
In contrast, the three main drivers of technology are expanding: integrated circuits account for 5.4%, electronic components for 6.0%, and electrical equipment and parts for 6.7%. The combined enthusiasm for these sectors clearly surpasses that of traditional consumer and medical industries.
To be honest, a 20-30 year industry cycle has reversed in this way. The once blue-chip stalwarts now have to give way to emerging industries, with capital flowing into hardware and advanced manufacturing. This reflects a profound adjustment in the economic structure—from being driven by consumption and healthcare to being driven by technology and manufacturing. The market is so ruthless; when the trend shifts, yesterday’s kings can easily become supporting roles.